BBC — Virtus Biotech Clinical Trials ETF
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Company profile
- Sector: Financial Services
- Industry: Asset Management
- Country: US
- Exchange: AMEX
- Website: https://www.virtus.com/products/virtus-biotech-clinical-trials-etf#shareclass./period.quarterly
Latest BBC news
- — Trasteel Holding S.A. Completes Acquisition of the Remaining 40% Interest in BBC Alloys S.r.l. (globenewswire.com)
Educational tool only — not investment advice.